in 2015 for assessing cancer status, as they ascertained objective measures of hepatic function (albumin and bilirubin) that independently affect the survival of HCC patients by utilizing data from extensive global databanks, assembling those to form a model comparable with the traditional C-P classification (42), which has a linear prediction equation of Linear prediction = (log10 bilirubin × 0.66)(albumin × -0.085), bilirubin in μmol/L and albumin in g/L. The gene discussed is ALB; the disease is cancer.